DRUG-THERAPY FOR CORONARY HEART-DISEASE - WHAT IS TREATABLE AND WHAT IS FEASIBLE IN PRACTICE

被引：0

|

作者：

NOSSEN, J

机构：

来源：

MUNCHENER MEDIZINISCHE WOCHENSCHRIFT | 1980年 / 122卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：36 / 37

页数：2

相关论文

共 50 条

[41] HEPARIN-THERAPY IN CORONARY HEART-DISEASE
GULBA, DC
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (01) : 35 - 36
[42] HEMORRHEOLOGICAL THERAPY OF CORONARY HEART-DISEASE WITH ARWIN
HOSSMANN, V
ROSSKAMP, A
GROTZ, J
GRIEBENOW, R
LAMBERS, U
ALT, U
SCHAFER, HJ
ESCHENFELDER, V
ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 39 - 39
[43] DIGITALIS THERAPY IN CHRONIC CORONARY HEART-DISEASE
ROSKAMM, H
CARDIOLOGY, 1980, 65 : 13 - 15
[44] HEMORHEOLOGIC APPROACHES IN THE THERAPY OF CORONARY HEART-DISEASE
LESCHKE, M
MOTZ, W
STRAUER, BE
WIENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 136 : 17 - 24
[45] THERAPY OF CORONARY HEART-DISEASE WITH DILTIAZEM AND NIFEDIPIN
BEYTHIEN, RD
HERZ KREISLAUF, 1982, 14 (09): : 509 - 513
[46] ANTIHYPERTENSIVE THERAPY AND THE RISK OF CORONARY HEART-DISEASE
AMES, RP
HILL, P
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 : S206 - S212
[47] DIGITALIS THERAPY IN CASES OF CORONARY HEART-DISEASE
SEIFERT, S
THERAPIE DER GEGENWART, 1978, 117 (08): : 1236 - &
[48] What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?
Otieno, Beryl
Ibecheozor, Chukwuka
Williams, Marlene S. S.
CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (07) : 343 - 350
[49] PLATELETS AND CORONARY HEART-DISEASE - THERAPY UPDATE
MEHTA, JL
GERIATRICS, 1982, 37 (05) : 129 - &
[50] What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?
Beryl Otieno
Chukwuka Ibecheozor
Marlene S. Williams
Current Atherosclerosis Reports, 2023, 25 : 343 - 350

← 1 2 3 4 5 →